Synovium-Derived Mesenchymal Stem Cells for Cartilage Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone and cartilage damage using stem cells are not effective, particularly in regenerating damaged cartilage, and there is a lack of reported methods for using cartilage stem cells in bone disease or inflammation treatment.
Innovation Solution
A method involving the preparation of synovium-derived mesenchymal stem cells using synovial tissue and a hydrogel, where the synovial tissue is encapsulated and cultured within the hydrogel, allowing the stem cells to migrate and proliferate, and then the hydrogel is degraded to recover the stem cells, which exhibit immunological characteristics and differentiate into adipocytes, osteocytes, and chondrocytes, with enhanced differentiation efficiency into chondrocytes using BMP-7, and are used in a pharmaceutical composition for treating bone or cartilage damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current stem cell treatments are used for bone and cartilage damage, then general tissue repair may occur, but the therapeutic effect is insufficient and cartilage regeneration is particularly poor
Solution Approach 1:
The invention changes the source parameter of stem cells from traditional bone marrow or adipose tissue to synovial tissue, which fundamentally alters the differentiation potential and therapeutic efficacy. Synovial-derived mesenchymal stem cells exhibit enhanced chondrogenic differentiation capacity compared to conventional stem cell sources, directly addressing the insufficient cartilage regeneration problem
Solution Approach 2:
The invention introduces a dual-carrier system consisting of hydrogel and scaffold as intermediaries. The hydrogel provides initial encapsulation and protection during injection, while the scaffold offers structural support and promotes tissue integration at the defect site. This intermediary system enhances the survival and functional integration of transplanted stem cells, thereby improving therapeutic reliability
2Productivity
If synovial tissue is encapsulated in hydrogel for culturing stem cells, then cell migration and proliferation are enhanced, but the process requires precise control of degradation and recovery timing
Solution Approach 1:
The hydrogel is designed with inherent degradability through incorporation of hydrolyzable bonds or enzyme-sensitive sequences. The degradation process occurs automatically under physiological conditions without requiring external intervention, allowing stem cells to migrate and proliferate freely as the hydrogel matrix gradually breaks down. This self-degrading mechanism simplifies the overall process while maintaining controlled cell release
Solution Approach 2:
The invention modifies the chemical composition parameters of the hydrogel to achieve optimal degradation kinetics. By adjusting crosslinking density, molecular weight, and compositional ratios of hydrophilic polymers, the hydrogel degradation rate is tuned to match the stem cell proliferation rate, ensuring cells are released at the appropriate time while maximizing proliferation benefits during the encapsulation period
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively regenerates damaged bone and cartilage, with improved therapeutic effects when combined with a BMP-7-loaded scaffold, demonstrating the potential for treating bone or cartilage damage through the use of synovium-derived mesenchymal stem cells.
Implementation Method 1
degrading the hydrogel in the obtained culture to recover, from the synovial tissue, the mesenchymal stem cells
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 2C~3A
AI summary
Provided are a method of preparing synovium-derived mesenchymal stem cells using a synovial tissue and a hydrogel, synovium-derived mesenchymal stem cells prepared by the method, a pharmaceutical composition for treating bone or cartilage damage, the pharmaceutical composition including the synovium-derived mesenchymal stem cells, and a composition and kit for culturing mesenchymal stem cells, the composition and kit including a synovial tissue and a hydrogel. When the preparation method of the present invention is used, stem cells may be effectively extracted and obtained from synovium, and the obtained synovium-derived mesenchymal stem cells may effectively treat bone or cartilage damage, and therefore, it will be able to greatly contribute to the development of a method of treating bone or cartilage damage.